Glucotrack, Inc. Net Income Loss

• Glucotrack, Inc. showed an increase of +14.2% in Net Income Loss from 2024 to 2025.
• This data is from Glucotrack, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
• XBRL data for this metric is available from 2005 to 2025 (21 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 21 years of available data (2005 to 2025), Glucotrack, Inc.'s Net Income Loss has declined by 1,736.7%.
• Historical annual values: Fiscal year 2025: -$19.39 million | Fiscal year 2024: -$22.60 million | Fiscal year 2023: -$7.10 million | Fiscal year 2022: -$4.44 million | Fiscal year 2021: -$4.07 million | Fiscal year 2020: -$2.70 million | Fiscal year 2019: $3.52 million | Fiscal year 2018: -$6.72 million | Fiscal year 2017: $10.33 million | Fiscal year 2016: -$5.41 million | Fiscal year 2015: -$5.84 million | Fiscal year 2014: $2.98 million | Fiscal year 2013: -$9.80 million | Fiscal year 2012: -$2.77 million | Fiscal year 2011: -$2.36 million | Fiscal year 2010: -$2.79 million | Fiscal year 2009: -$1.20 million | Fiscal year 2008: -$1.53 million | Fiscal year 2007: -$1.59 million | Fiscal year 2006: -$1.28 million | Fiscal year 2005: -$1.06 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026